Login / Signup

Modular Diazo Compound for the Bioreversible Late-Stage Modification of Proteins.

Joomyung V JunYana D PetriLucas W EricksonRonald T Raines
Published in: Journal of the American Chemical Society (2023)
We introduce a versatile strategy for the bioreversible modification of proteins. Our strategy is based on a tricomponent molecule, synthesized in three steps, that incorporates a diazo moiety for chemoselective esterification of carboxyl groups, a pyridyl disulfide group for late-stage functionalization with thiolated ligands, and a self-immolative carbonate group for esterase-mediated cleavage. Using cytochrome c (Cyt c ) and the green fluorescent protein (GFP) as models, we generated protein conjugates modified with diverse domains for cellular delivery that include a small molecule, targeting and cell-penetrating peptides (CPPs), and a large polysaccharide. As a proof of concept, we used our strategy to effect the delivery of proteins into the cytosol of live mammalian cells in the presence of serum. The cellular delivery of functional Cyt c , which induces apoptosis, highlighted the advantage of bioreversible conjugation on a carboxyl group versus irreversible conjugation on an amino group. The ease and utility of this traceless modification provide new opportunities for chemical biologists.
Keyphrases
  • living cells
  • single molecule
  • small molecule
  • protein protein
  • amino acid
  • cancer therapy
  • binding protein
  • bone marrow
  • mesenchymal stem cells
  • dna binding
  • quantum dots